Efficacy and safety of abobotulinumtoxinA in pediatric lower limb spasticity: 2nd interim results from a phase IV, prospective, observational, multicenter study

Authors

Mark E. Gormley, Gillette Children's Specialty Healthcare, St. Paul, MN
Edward Dabrowski, Oakland University School of Medicine, Grosse Point, MI
Ann Tilton, LSU Health Sciences Center - New OrleansFollow
Asare Christian, Good Shepherd Rehabilitation Hospital, Allentown, PA
Sarah Helen Evans, Children's Hospital of Philadelphia, Philadelphia, PA
Pascal Maisonobe, Ipsen, Boulogne-Billancourt,Ile-de-France, France
Stefan Wietek, Ipsen, Cambridge, MA

Document Type

Conference Proceeding

Publication Date

9-21-2020

Publication Title

Developmental Medicine and Child Neurology

Abstract

74th Annual Meeting of the American Academy for Cerebral Palsy and Developmental Medicine, September 24 - 26, 2020, Virtual

First Page

117

Volume

62

Issue

Supplement 3

Comments

Abstract SP68

Rights

© 2020 The Authors. Developmental Medicine & Child Neurology © 2020 Mac Keith Press

Recommended Citation

Gormley, Mark E.; Dabrowski, Edward; Tilton, Ann; Christian, Asare; Evans, Sarah Helen; Maisonobe, Pascal; and Wietek, Stefan, "Efficacy and safety of abobotulinumtoxinA in pediatric lower limb spasticity: 2nd interim results from a phase IV, prospective, observational, multicenter study" (2020). School of Medicine Faculty Publications. 4145.
https://digitalscholar.lsuhsc.edu/som_facpubs/4145
10.1111/dmcn.14662